Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice

被引:72
作者
Liu, YJ
Nakagawa, Y
Wang, Y
Li, RS
Li, XJ
Ohzeki, T
Friedman, TC
机构
[1] Charles R Drew Univ Med & Sci, Univ Calif Los Angeles, Div Endocrinol, Sch Med, Los Angeles, CA 90059 USA
[2] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 43131, Japan
[3] Charles R Drew Univ Med & Sci, Univ Calif Los Angeles, Dept Internal Med, Div Lab Res & Dev,Sch Med, Los Angeles, CA 90059 USA
[4] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Cardiol, Los Angeles, CA 90048 USA
关键词
D O I
10.2337/diabetes.52.6.1409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids have been implicated as pathophysiological mediators of obesity and insulin resistance and are regulated by 11beta-hydrokysteroid dehydrogenase type 1 (11beta-HSD1). This enzyme regenerates active corticosterone from inactive 11-keto forms. To assess the role of 11beta-HSD1-mediated synthesis of active corticosterone in leptin-related obesity and diabetes; we examined the peripheral effect of leptin on 11beta-HSD1 activity. and gene expression in vivo and in vitro in hepatocytes from ob/ob mice and in liver of streptozotocin (STZ)-treated ob/ob mice. We observed an inverse relationship between hepatic 11beta-HSD1 expression and body weight in ob/ob mice and lean littermates. Leptin treatment of ob/ob mice markedly increased hepatic 11beta-HSD1 activity and mRNA expression. This induction of 11beta-HSD1 expression, corresponded to reduced levels of circulating corticosterone and weight loss in ob/ob mice treated with leptin, indicating that impaired hepatic 11beta-HSD1 expression may contribute to the pathogenesis. of obesity in ob/ob mice. In addition, leptin treatment of STZ-treated ob/ob mice caused marked increases in hepatic 11beta-HSDl levels associated with decreased body weight and a significant reduction in hyperglycemia due to pancreatic beta-cell damage. Addition of leptin to ob/ob mouse primary hepatocytes led to a dose-dependent increase in 11beta-HSD1 mRNA expression. In contrast, leptin did not influence 11beta-HSD1 expression in primary hepatocytes from db/db mice, indicating that leptin regulation of 11beta-HSD1 expression is probably mediated by the functional leptin receptor. Thus, leptin appears to be an important metabolic signal that directly activates intrahepatic corticosterone production. These findings suggest that the liver-specific interaction of leptin with 11beta-HSD1 is involved in the development of obesity and insulin resistance in ob/ob mice.
引用
收藏
页码:1409 / 1416
页数:8
相关论文
共 48 条
[1]  
Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
[2]   Leptin selectively decreases visceral adiposity and enhances insulin action [J].
Barzilai, N ;
Wang, JL ;
Massilon, D ;
Vuguin, P ;
Hawkins, M ;
Rossetti, L .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3105-3110
[3]   Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity [J].
Berger, J ;
Tanen, M ;
Elbrecht, A ;
Hermanowski-Vosatka, A ;
Moller, DE ;
Wright, SD ;
Thieringer, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) :12629-12635
[4]   Obesity and cortisol [J].
Björntorp, P ;
Rosmond, P .
NUTRITION, 2000, 16 (10) :924-936
[5]  
BJORNTORP P, 1991, J INTERN MED, V230, P195
[6]   Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland - Leptin inhibits cortisol release directly [J].
Bornstein, SR ;
Uhlmann, K ;
Haidan, A ;
EhrhartBornstein, M ;
Scherbaum, WA .
DIABETES, 1997, 46 (07) :1235-1238
[7]   GENETIC AND NONGENETIC DETERMINANTS OF REGIONAL FAT DISTRIBUTION [J].
BOUCHARD, C ;
DESPRES, JP ;
MAURIEGE, P .
ENDOCRINE REVIEWS, 1993, 14 (01) :72-93
[8]   Does central obesity reflect ''Cushing's disease of the omentum''? [J].
Bujalska, IJ ;
Kumar, S ;
Stewart, PM .
LANCET, 1997, 349 (9060) :1210-1213
[9]   Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat [J].
Chinookoswong, N ;
Wang, JL ;
Shi, ZQ .
DIABETES, 1999, 48 (07) :1487-1492
[10]   Modulation of insulin activities by leptin [J].
Cohen, B ;
Novick, D ;
Rubinstein, M .
SCIENCE, 1996, 274 (5290) :1185-1188